Back

Oral anticoagulation regimen after left atrial appendage occlusion in elderly atrial fibrillation patients with versus without cardiovascular comorbidities

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Left atrial appendage closure: outcomes and evidence Left Atrial Appendage Closure ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sanghamitra Mohanty

St. David's Medical Center, Austin (United States of America)

6 More presentations in this session

Presentation thumbnail
Efficacy and safety of left atrial appendage closure versus oral anticoagulation in atrial fibrillation: a two-part randomised-trial synthesis and a pooled analysis
Doctor H. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Left atrial appendage occlusion for atrial fibrillation–related stroke despite chronic oral anticoagulation
Mr L. Giovachini (Paris, FR)
Abstract Slides
Presentation thumbnail
Clinical utility of one-year transesophageal echocardiography after left atrial appendage closure: a tertiary care center experience
Doctor J. Veillette (Quebec, CA)
Abstract Slides Video
Presentation thumbnail
Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: updated evidence from a systematic review and meta-analysis
Doctor C. Wang (Hangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Closure of the left atrial appendage: CLOSURE-AF vs. nationwide routine care in Germany
Doctor J. Voran (Kiel, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Left atrial appendage closure: outcomes and evidence

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Role of left atrial appendage occlusion versus direct oral anticoagulants in elderly patients (>80 years) with atrial fibrillation: a retrospective cohort analysis
29 August 2025
thumbnail
Congress Presentation
Half-Dose Anticoagulation versus Standard Antiplatelet Therapy for Preventing Silent Cerebral Embolism After Left Atrial Appendage Occlusion: The HALO-SCE Randomized Trial
31 August 2026
thumbnail
Congress Presentation
Patterns of comorbidities in atrial fibrillation patients with high thromboembolic risks: a latent class analysis of two prospective registries from the Asia-Pacific and Europe
30 August 2025
thumbnail
Congress Presentation
Embolic events after left atrial appendage closure for recurrent embolic events despite anticoagulation
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources